| |
| |
| Catalent Acquires Additional Facility for Commercial-Scale pDNA Manufacturing | | The company expands its Gosselies, Belgium, campus with the acquisition of a 32,400 square-foot facility to accommodate commercial-scale plasmid DNA (pDNA) manufacturing capability. Catalent will offer up to 500-liter scale capacity in Belgium and at its facility in Rockville, Maryland. |
|
|
|
|
| |
| |
| |
| |
| Catalent is Proud to Support Many High-Profile COVID-19 Programs
Catalent has been awarded more than 80 COVID-19-related compounds including antivirals, vaccines, diagnostics and treatments across our biologics, gene therapy, oral technologies, softgel and clinical supply businesses. Catalent is on track to deliver over one billion COVID-19 vaccine and treatment doses in 2021, and its COVID-19 efforts were covered in a recent article published in Fortune . |
|
|
|
|
| |
| |
| The Medicine Maker Power List 2021
Catalent is delighted that John Chiminski, Catalent's CEO & Chair, and Karen Flynn, President, Biologics & Chief Commercial Officer, have been included in this year's The Medicine Maker Power List. |
|
|
|
|
| |
| |
| Financial Times Interview with John Chiminski
Catalent CEO Johh Chiminski discusses how the pandemic has made us question how the future of pharma manufacturing will be altered post Covid-19. |
|
|
|
|
| |
| |
| AavantiBio and Catalent Partner to Support Development and Manufacturing of Gene Therapies for Rare Genetic Diseases
Catalent will provide process development and CGMP manufacturing of AavantiBio’s adeno-associated viral vector-based therapeutic candidate. |
|
|
|
|
| |
| |
| Catalent Establishes Energy-Efficient Cold Chain Capabilities
The partnership with Stirling Ultracold has already seen the delivery and installation of over 200 state-of-the-art freezers, with a further 60 planned. |
|
|
|
|
| |
| |
| Hofseth BioCare Announces Global Innovation Partnership with Catalent to Develop Delayed-Release Formulation of OmeGo® Fish Oil
The partnership will see Catalent use its OptiGel® DR technology to encapsulate OmeGo, HBC’s unique fish oil derived from sustainable, traceable, and fresh Norwegian Atlantic salmon. |
|
|
|
|
| |
| |
| Catalent Biologics’ Facility Expansion and its Partnership with Moderna Covered by BioProcess International
Catalent Biologics experts were interviewed by BioProcess International about the company’s recent expansion of its Madison, Wisconsin facility. |
|
|
|
|
| |
| |
| |
| |
| Join Our Experts at Live Virtual Events to Hear the Latest on COVID-19 and Technology Development Programs |
|
|
|
|
| Biologics
Pharma Manufacturing | Virtual Conference | May 18 – 19 Natasha Van Rutten, Product Development Director, Catalent Biologics, will present “Accelerating Drug Product Tech Transfers” as part of the “Sterile Manufacturing” session.
Webinar | Delivering a Successful Therapeutic to Patients | May 20 Experts discuss the trends driving growth in the pharma industry, and the ways next generation therapies can address previously unmet needs.
Webinar | Advances in Downstream Intensification, Purification, and Continuous Bioprocessing | May 26 Catalent’s Aaron Almeida, Manager, Manufacturing Process Optimization, will present “Evaluation of a Next-Gen Downstream Approach to Improve Overall Manufacturing Process Intensity” and Ben Kester, Manager, Purification Development, will join a panel session.
PBSS – Antibody-Drug Conjugates: Discovery to Development | Virtual | May 26 Penelope Drake, Ph.D., Head of R&D, Bioconjugates, Catalent Biologics, will present “Catalent’s SMARTag® Technology: Precision-Based ADC Design”.
ASCO Explained | Virtual Conference | June 3 Panelists, including Mike Riley, Region President, North America, Catalent Biologics, will look at oncology’s hottest fields, including CAR-T and precision medicine, zero in on the conference’s most highly anticipated studies, and 2021’s biggest research trends.
BIO International | Virtual Conference | June 14 - 17 Meet with Catalent at BIO International. |
|
|
|
|
| Cell & Gene Therapy
World Medical Innovation Forum | Virtual Conference | May 19 – 21 Thomas VanCott, Ph.D., Vice President and Global Head of Product Development, Cell & Gene Therapy, Catalent will discuss the challenges associated with manufacturing cell and gene therapies.
ISCCR Digital Series – Cell Manufacturing | Virtual | May 24 & June 1 Meet with Catalent at ISCCR Digital Series.
ISCT | Virtual Conference | May 26 - 28 Meet with Catalent at ISCT.
Webinar | Reengineering for Solid Tumors | May 27 Philip Wills, Ph.D., Chief Commercial Officer, Catalent Cell & Gene Therapy, discusses the ways CAR-Ts can revolutionize the way blood cancers can be treated.
ISCCR Digital – Workshop on Clinical Translation | Virtual Conference | June 7 Meet with Catalent at ISCCR Digital – Workshop on Clinical Translation.
Next Gen: What’s Beyond the Leading Edge of Biotech and Pharma? | Virtual | June 22-23 Manja Boerman, Ph.D., President, Catalent Cell & Gene Therapy will join a panel session titled, “What’s Next in Gene Therapy?”, Behzad Mahdavi, Ph.D., Open Innovation, Catalent Biologics and Cell & Gene Therapy, will present “Manufacturing of New Modalities: New Opportunities Come with New Challenges”, and Mike Riley, Region President, North America, Catalent Biologics will take part in an exclusive interview session. |
|
|
|
|
| |
| |
| A Catalyst in Drug Development | | Todd Stone, Ph.D. Senior Manager, Analytical & Formulation Development, Biologics |
|
|
|
|
| Dr. Stone and his team develop statistically rigorous analytical methods and high throughput formulation strategies using Quality by Design (QbD) principles. Dr. Stone leads the scientific direction of the analytical and formulation groups to provide clients with the highest quality data characterizing the critical quality attributes of their molecules. He received a bachelor’s degree in chemistry from the University of Virginia, his doctorate in chemical physics from Indiana University, Bloomington, and was also a Harvard fellow in chemical physics. |
|
| | |
|
|
| |
| |
| |
| |
| |
| |
| |
| Consumer Health
Webinar: “Where to Innovate in OTC?” - In this webinar, Catalent partnered with NielsenIQ to suggest new insights to re-establish growth in the OTC market through innovation. Webinar: “The Emergence of Inner Beauty” - Inner Beauty, also known as Beauty Nutrition, is one of the fastest growing categories in the nutritional supplements market. In this webinar, in partnership with Mintel, we explore the market trends and how to bring those trends to life. Webinar: “The Emergence of Outer Beauty” - In this webinar, we explore the trends, innovations, and the lasting impact that topical beauty will have in the future. |
|
|
|
|
| We are the Catalyst for your Success. Join Us! |
|
|
|
|
| Catalent ignites the development of their future leaders by continuously investing in their employees and creating an innovative environment to advance their potential. We are growing rapidly across sites in Bloomington, Indiana; Madison, Wisconsin; Harmans, Maryland; Kansas City, Missouri; and more.
Visit www.catalent.com/careers for more information. |
|
|
|
|
| |
| |
| Every brand has a challenge. We have a solution. | | | | or call +1 877 891 9609 to speak with one of our experts today! | | |
|
|
|
|
| |
| To unsubscribe or manage your subscriptions, please click here.
For more information call +1-866-720-3148 or in Europe 00800 88 55 6178, email us at sales@catalent.com, or visit our website www.catalent.com. And to learn more about Career opportunities across our global network, visit www.catalent.com/careers. Catalent Pharma Solutions respects your privacy. Links to third party sites are provided as a convenience only. Catalent makes no representation or warranty about the technology, security or any content available at these sites. Links are not intended to imply Catalent's affiliation or endorsement of the website, its owner(s) or the content. © 2020, Catalent Pharma Solutions, Inc. 14 Schoolhouse Road, Somerset, NJ 08873. All rights reserved. |
|
|
|
|
| |
